News › Industry News, Patient Care

Makers of Ozempic and Mounjaro Sued over ‘Stomach Paralysis’ Claims

August 3, 2023

The drugmakers Novo Nordisk and Eli Lilly failed to adequately warn patients about the possible risk of severe stomach problems associated with their blockbuster drugs Ozempic and Mounjaro, according to a lawsuit filed Wednesday.

The 26-page lawsuit, filed on behalf of a Louisiana woman who says she was “severely injured” after taking the two diabetes drugs, is the first to allege that they can cause gastrointestinal injuries.

Read more at NBC News >>

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • Medicare GLP-1 Bridge Program Launches July 1, Expanding Access for Some Patients
    • Universal Healthcare Consulting Becomes Platinum Vendor Affiliate with the American Med Spa Association
    • DAW Systems Earns First Artificial Intelligence Accreditation from DirectTrust
    • Estée Lauder Executive’s Death Linked to Pulmonary Embolism Following Cosmetic Filler Injection
    • Allergan Aesthetics Receives Approval for Boey® (trenibotulinumtoxinE) in Canada
Advertisement